Total Payments
$835.88
2024 Payments
$240.34
Companies
14
Transactions
37
Medicare Patients
7,035
Medicare Billing
$562,766
Payment Breakdown by Category
Food & Beverage$734.48 (87.9%)
Education$101.40 (12.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $734.48 | 31 | 87.9% |
| Education | $101.40 | 6 | 12.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $213.42 | 9 | $0 (2024) |
| Medtronic, Inc. | $141.86 | 1 | $0 (2024) |
| Amgen Inc. | $76.93 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $69.09 | 3 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $65.99 | 4 | $0 (2021) |
| Janssen Biotech, Inc. | $52.63 | 3 | $0 (2023) |
| Kite Pharma, Inc. | $44.41 | 2 | $0 (2023) |
| Exelixis Inc. | $41.20 | 1 | $0 (2021) |
| Seattle Genetics, Inc. | $36.87 | 3 | $0 (2018) |
| GENZYME CORPORATION | $32.29 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.34 | 5 | Medtronic, Inc. ($141.86) |
| 2023 | $174.99 | 8 | PFIZER INC. ($71.18) |
| 2022 | $208.07 | 11 | PFIZER INC. ($65.27) |
| 2021 | $89.32 | 4 | Exelixis Inc. ($41.20) |
| 2020 | $58.93 | 4 | GENZYME CORPORATION ($32.29) |
| 2019 | $27.36 | 2 | Merck Sharp & Dohme Corporation ($27.36) |
| 2018 | $36.87 | 3 | Seattle Genetics, Inc. ($36.87) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $141.86 | General |
| Category: Surgical Stapling | ||||||
| 05/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: ONCOLOGY | ||||||
| 03/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: ONCOLOGY | ||||||
| 01/16/2024 | Daiichi Sankyo Inc. | Vanflyta (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: ONCOLOGY | ||||||
| 06/28/2023 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 02/28/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Oncology | ||||||
| 02/19/2023 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Oncology | ||||||
| 02/06/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: ONCOLOGY | ||||||
| 02/03/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: Oncology | ||||||
| 01/24/2023 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Oncology | ||||||
| 01/05/2023 | PFIZER INC. | BOSULIF (Drug), BESPONSA | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 11/28/2022 | Amgen Inc. | Nplate (Biological), XGEVA | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Hematology | ||||||
| 11/14/2022 | Kite Pharma, Inc. | — | Food and Beverage | In-kind items and services | $22.21 | General |
| 11/07/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, COMIRNATY | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2022 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: ONCOLOGY | ||||||
| 09/22/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: ONCOLOGY | ||||||
| 08/18/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: ONCOLOGY | ||||||
| 05/17/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Oncology | ||||||
| 04/29/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Oncology | ||||||
| 03/15/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Oncology | ||||||
| 02/18/2022 | Amgen Inc. | Kyprolis (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Oncology | ||||||
| 11/01/2021 | Exelixis Inc. | — | Education | In-kind items and services | $41.20 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,615 | 4,203 | $347,740 | $133,203 |
| 2022 | 12 | 1,719 | 4,115 | $348,702 | $134,197 |
| 2021 | 12 | 1,760 | 4,826 | $380,866 | $147,930 |
| 2020 | 13 | 1,941 | 5,439 | $420,354 | $147,436 |
Total Patients
7,035
Total Services
18,583
Medicare Billing
$562,766
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 446 | 783 | $142,427 | $66,655 | 46.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 106 | 140 | $33,858 | $18,136 | 53.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 424 | 1,566 | $70,470 | $11,693 | 16.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 423 | 1,376 | $33,024 | $11,265 | 34.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $19,047 | $8,628 | 45.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 48 | $16,368 | $5,856 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $11,578 | $4,739 | 40.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 40 | $8,360 | $3,231 | 38.6% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 40 | 138 | $11,178 | $2,212 | 19.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $1,430 | $789.52 | 55.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 449 | 816 | $139,536 | $69,901 | 50.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 91 | 122 | $28,548 | $15,723 | 55.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 440 | 1,468 | $66,060 | $11,154 | 16.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 52 | $17,732 | $7,753 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $17,292 | $7,710 | 44.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 47 | 47 | $15,651 | $7,633 | 48.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 70 | $14,630 | $5,498 | 37.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 440 | 1,266 | $30,384 | $3,733 | 12.3% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2022 | 41 | 143 | $11,583 | $2,421 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 31 | $3,534 | $1,378 | 39.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 18 | 18 | $3,096 | $1,058 | 34.2% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 16 | 16 | $656.00 | $234.75 | 35.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 450 | 886 | $151,506 | $79,893 | 52.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 443 | 1,680 | $75,542 | $12,968 | 17.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 70 | 89 | $20,826 | $11,463 | 55.0% |
About Dr. Duane Moores, M.D
Dr. Duane Moores, M.D is a Hematology & Oncology healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598755191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Duane Moores, M.D has received a total of $835.88 in payments from pharmaceutical and medical device companies, with $240.34 received in 2024. These payments were reported across 37 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($734.48).
As a Medicare-enrolled provider, Moores has provided services to 7,035 Medicare beneficiaries, totaling 18,583 services with total Medicare billing of $562,766. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Brunswick, GA
- Active Since 10/25/2005
- Last Updated 09/26/2023
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1598755191
Products in Payments
- XTANDI (Drug) $187.66
- SIGNIA (Device) $141.86
- PROMACTA (Drug) $69.09
- Kyprolis (Drug) $57.73
- KEYTRUDA (Biological) $53.58
- ADCETRIS (Biological) $36.87
- LIBTAYO (Biological) $32.29
- ERLEADA (Drug) $29.55
- BOSULIF (Drug) $25.76
- RYBREVANT (Drug) $23.08
- Vanflyta (Drug) $21.51
- Nplate (Biological) $19.20
- Nubeqa (Drug) $16.35
- LYNPARZA (Biological) $12.41
- OPDIVO (Biological) $11.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Brunswick
Dr. Abraham Cheong, M.d, M.D
Hematology & Oncology — Payments: $17,794
Hematology & Oncology $17,794
Edgardo Ortiz Flores, M.d, M.D
Hematology & Oncology — Payments: $4,718
Hematology & Oncology $4,718
Madelaine Sgroi, Do, DO
Hematology & Oncology — Payments: $3,531
Hematology & Oncology $3,531
Su-Chiao Kuo, Md, MD
Hematology & Oncology — Payments: $2,089
Hematology & Oncology $2,089
Hillary Glick, M.d, M.D
Hematology & Oncology — Payments: $215.16
Hematology & Oncology $215.16
Allison Smith, M.d, M.D
Hematology & Oncology — Payments: $214.98
Hematology & Oncology $214.98